Eli Lilly and Co.’s success at moving an experimental migraine medicine forward by using outside companies and capital is good news for this reason: The fundamental business of Big Pharma drug development is in bad shape.
New research shows that expanding Medicaid won’t save money, in spite of the claims of Obamacare supporters, but it will provide modest help to patients’ health and pocketbooks, in spite of conservative critics’ contention to the contrary.
Positive results from a Phase 2 trial in patients convinced Lilly to reacquire an experimental migraine medicine. Lilly recorded a charge of $57 million to reflect the purchase price and the costs of further development.
Family and Social Services Administration Secretary Debra Minott announced Friday the state had culled through an extensive waiting list and accepted the new applicants for coverage.
Two Indiana University School of Optometry professors are tackling diagnosis of one of the most difficult medical problems facing sports teams at every level: head injuries.
Nationally, venture capital investments into life sciences firms totaled $4.9 billion during the first nine months of 2013, down 30 percent from the same period in 2008, according to data from Thomson Reuters and PricewaterhouseCoopers. In Indiana, life sciences firms raised $21 million during the first nine months of the year, far lower than any year since 2003.
The Blue Cross and Blue Shield Association will form a combined provider network with London-based Bupa that will collectively include more than 11,500 hospitals in more than 190 countries, the partners said Thursday.
Commercial tanning beds may soon be off limits to Hoosiers younger than 16 under a bill approved Wednesday by the Senate Health and Provider Services Committee.
A hearing about tobacco funding Wednesday in the House Public Health Committee left many legislators still searching for answers.
Two of the largest U.S. health insurers are giving Obamacare customers more time to pay their initial premiums as the industry tries to coax millions of people to take the final step in cementing coverage for 2014.
Financial terms of the sale to Boston-based private equity firm Thomas H. Lee Partners LP weren’t disclosed. WellPoint paid a reported $900 million to buy the company in June 2012.
In a warning shot to investors, the pharmaceutical giant says it expects “2014 to be the most financially challenging year of Lilly’s current period of patent expirations.”
It’s a challenging time to be a hospital CEO, but when Jonathan Nalli takes the helm of St. Vincent Health, he’ll have about as strong a financial hand as anybody to play.
When Gov. Mike Pence tries next month to negotiate a Medicaid expansion deal in a meeting with the Obama administration, it will be a clash of the conservative and liberal approaches to fighting poverty.
Careers in science, technology, engineering and math—typically referred to as STEM fields—have surged in growth compared to other careers in Marion and Hamilton counties. But the rest of Indiana has barely budged from the early 2000s.
The university wants to expand its health services program by using some existing Wishard space and tearing down other buildings and replacing them with modern facilities,
Obamacare has officially arrived, but both conservatives and liberals are calling it awful. That means the real debate over health reform is just beginning.
After a troubled rollout, President Barack Obama's health care overhaul now faces its most personal test: How will it work as people seek care under its new mandates?
The so-called "young invincibles" are so important to the success of the Affordable Care Act that supporters and detractors are spending millions to reach them.
The Supreme Court has thrown a hitch into President Barack Obama's new health care law by blocking a requirement that some religion-affiliated organizations provide health insurance that includes birth control.
